Terms: = Uterine cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
166 results:
1. The KRAS, atr and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.
Buchynska L; Gordiienko I; Glushchenko N; Iurchenko N
PLoS One; 2024; 19(4):e0302075. PubMed ID: 38669256
[TBL] [Abstract] [Full Text] [Related]
2. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract] [Full Text] [Related]
3. Inclusion Complexes of
Pante GC; Castro JC; Lini RS; Romoli JCZ; Pires TY; Garcia FP; Nakamura CV; Mulati ACN; Matioli G; Machinski Junior M
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611905
[TBL] [Abstract] [Full Text] [Related]
4. Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database.
Chen Q; Zhao J; Xue X; Xie X
BMC Womens Health; 2024 Jan; 24(1):75. PubMed ID: 38281955
[TBL] [Abstract] [Full Text] [Related]
5. Detection of Sialic Acid to Differentiate Cervical cancer Cell Lines Using a
Zamudio Cañas R; Jaramillo Flores ME; Vallejo Ruiz V; Delgado Macuil RJ; López Gayou V
Biosensors (Basel); 2024 Jan; 14(1):. PubMed ID: 38248411
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer.
Kushwah AS; Masood S; Mishra R; Banerjee M
Crit Rev Oncol Hematol; 2024 Feb; 194():104240. PubMed ID: 38122918
[TBL] [Abstract] [Full Text] [Related]
7. A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.
Chen LM; Cong Q; Wu D; Chen Y; Qiu LH; Hong ZB; Yang YB; Xu L; Wang LF; Huang LX; Li WR; Tang JP; Cao YG; Sui L
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):8985-8992. PubMed ID: 37843310
[TBL] [Abstract] [Full Text] [Related]
8. HIV and Early Treatment Outcomes Among Women With Cervical cancer Treated With Concurrent Chemoradiation in Tanzania.
Mrema AS; Ngoma M; Josiah C; Lugina E; Mvungi N; Paul M; Mkuchika E; Nundu E; Iddy SK; Rugengamanzi E; Vuhahula YM; Kiwanga FC; Wood C; Mwaiselage J
JCO Glob Oncol; 2023 Sep; 9():e2200441. PubMed ID: 37738537
[TBL] [Abstract] [Full Text] [Related]
9. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia.
Bogani G; Sopracordevole F; Ciavattini A; Vizza E; Vercellini P; Giannini A; Ghezzi F; Scambia G; Raspagliesi F; Di Donato V;
Eur J Cancer Prev; 2023 Nov; 32(6):525-532. PubMed ID: 37401466
[TBL] [Abstract] [Full Text] [Related]
10. High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma.
Knipprath-Mészáros AM; Tozzi A; Butenschön A; Reina H; Schoetzau A; Montavon C; Heinzelmann-Schwarz V; Manegold-Brauer G
Gynecol Oncol; 2023 Jul; 174():182-189. PubMed ID: 37210928
[TBL] [Abstract] [Full Text] [Related]
11. Endocervical curettage for diagnosing high-grade squamous intraepithelial lesions or worse in women with type 3 transformation zone lesions: a retrospective, observational study.
Wei B; Li Q; Seery S; Qiao Y; Jiang Y
BMC Womens Health; 2023 May; 23(1):245. PubMed ID: 37161558
[TBL] [Abstract] [Full Text] [Related]
12. uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract] [Full Text] [Related]
13. Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K/AKT pathway.
Wei Y; Lin S; Zhi W; Chu T; Liu B; Peng T; Xu M; Ding W; Cao C; Wu P
J Med Virol; 2023 Mar; 95(3):e28656. PubMed ID: 36905114
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.
Yang X; Yin J; Fu Y; Shen Y; Zhang C; Yao S; Xu C; Xia M; Lou G; Liu J; Lin B; Wang J; Zhao W; Zhang J; Cheng W; Guo H; Guo R; Xue F; Wang X; Han L; Li X; Zhang P; Zhao J; Li W; Dou Y; Wang Z; Liu J; Li K; Chen G; Sun C; Sun P; Lu W; Yao Q
Diagn Pathol; 2023 Jan; 18(1):8. PubMed ID: 36698195
[TBL] [Abstract] [Full Text] [Related]
15. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
Jiang W; Ouyang X; Ji Z; Shi W; Wu Y; Yao Q; Wang Y; Yang W; Xiang L; Yang H
Cancer Lett; 2023 Mar; 556():216064. PubMed ID: 36646410
[TBL] [Abstract] [Full Text] [Related]
16. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (atr) kinase inhibitor.
Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
[TBL] [Abstract] [Full Text] [Related]
17. Elimusertib (BAY1895344), a novel atr inhibitor, demonstrates in vivo activity in atrX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania.
Maillie L; Yussuph A; Chirangi B; Schroeder K
Int J Gynaecol Obstet; 2023 Feb; 160(2):604-611. PubMed ID: 36052864
[TBL] [Abstract] [Full Text] [Related]
19. Research Progress in the Relationship Between P2X7R and Cervical cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract] [Full Text] [Related]
20. Predictors of cervical cancer knowledge and attitude among Saudi women in Najran city: A cross-sectional study.
Elgzar WT; Al-Thubaity DD; Alshahrani MA; Nahari MH; Ibrahim HA; Sayed SH; El Sayed HA
Afr J Reprod Health; 2022 Jul; 26(7s):23-32. PubMed ID: 37585007
[TBL] [Abstract] [Full Text] [Related]
[Next]
